Voriconazole injection use in patients receiving continuous renal replacement therapy. [PDF]
Zhou L, Yu Z, Wang X, Zheng H.
europepmc +1 more source
ABSTRACT Background Therapeutic resistance limits durable survival in advanced/metastatic renal cell carcinoma (RCC) treated with first‐line tyrosine kinase inhibitor (TKI) plus immune checkpoint inhibitor (ICI). We sought to define key resistance drivers and actionable targets.
Jinchen Luo +16 more
wiley +1 more source
Predictive value of FST for renal replacement therapy in patients with acute kidney injury: a meta-analysis. [PDF]
Zhao C +7 more
europepmc +1 more source
A NIR‐II light‐activatable thermoelectric nanoreactor converts surface‐bound Cu2+ into bioactive Cu+ via directed electron flow. This spatiotemporally controlled reduction triggers potent cuproptosis and immunogenic cell death, eradicating primary tumors and, together with aPD‐1 therapy, suppressing metastases while establishing durable immune memory ...
Boyu Yuan +10 more
wiley +1 more source
Vascular access in Pará: clinical and epidemiological aspects of patients on renal replacement therapy at the largest specialist center in Pará state, Brazil. [PDF]
Dos Reis JMC +6 more
europepmc +1 more source
Renal Replacement Therapy in the Critically Ill Child*
C. Westrope +4 more
semanticscholar +1 more source
RHINO: An Integrative Multi‐Omics Framework Linking Circadian Physiology to Precision Medicine
RHINO (RHythmic Interacting Network for multi‐Omics) is an integrative framework that maps circadian regulation across diverse genetic and disease contexts and prioritizes druggable circadian targets. Released as an AI‐powered interactive web portal, RHINO unifies genetic, regulatory, disease, and drug–target information, enabling context‐specific ...
Ying Chen +12 more
wiley +1 more source
Summary of best evidence for nutritional management in adult patients undergoing continuous renal replacement therapy. [PDF]
Jia L, Wei J, Zhu K, Wang X, Sun Y.
europepmc +1 more source
A highly sensitive SERS‐based platform measures PD‐L1 expression on EpCAM+ circulating EVs from cancer patients undergoing immunotherapy. Monitoring dynamic changes after treatment reveals that reduced EpCAM+ EV PD‐L1 levels associate with improved long‐term clinical outcomes, establishing a non‐invasive approach for tracking immune checkpoint ...
Byeonggeol Mun +15 more
wiley +1 more source
Prognostic Factors of 30-Day In-Hospital Mortality in Critically Ill Patients Receiving Continuous Renal Replacement Therapy. [PDF]
Lee HJ +5 more
europepmc +1 more source

